Zobrazit v EDS

Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy

Uloženo v:
Podrobná bibliografie
Název: Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy
Autoři: Yadav, Amit Singh, Aydemir, Umut, Hellman, Karin, Ekström, Peter, Mousa, Abdelrazek H, Li, Jiaxin, Shameem, Muhammad Anwar, Dicko, Cedric, Bengzon, Johan, Ek, Fredrik, Hjort, Martin, Olsson, Roger
Přispěvatelé: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson's disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson's disease, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Chemical Biology and Therapeutics, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Kemisk biologi med inriktning mot läkemedelsutveckling, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Faculty of Science, Department of Physics, Particle and nuclear physics, Lunds universitet, Naturvetenskapliga fakulteten, Fysiska institutionen, Partikel- och kärnfysik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Neurosurgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Neurokirurgi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of stem cell research, Stem Cell Center, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för stamcellsforskning, Stamcellscentrum (SCC), Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Food and Bio, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Livsmedel och bioteknik, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Faculty of Science, Department of Chemistry, Center for Molecular Protein Science, Pure and Applied Biochemistry, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för Molekylär Proteinvetenskap, Tillämpad biokemi, Originator, Lund University, Faculty of Science, Department of Chemistry, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Originator, Lund University, Faculty of Engineering, LTH, Other operations, LTH, Lund Laser Centre, LLC, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Lunds lasercentrum, LLC, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Epilepsy Center, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Epilepsicentrum, Originator, Lund University, Faculty of Science, Department of Chemistry, Centre for Analysis and Synthesis, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för analys och syntes, Originator
Zdroj: Nature Communications. 16(1)
Témata: Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi
Popis: Current electrode technologies are too rigid for safe and effective delivery of electrotherapy in the brain, and patients with glioblastoma continue to face a devastating prognosis, with median survival stalled at 15 months despite intensive treatment with surgery, radiation, and chemotherapy. But these conventional approaches potentially compromise immune function, underscoring the urgent need for therapies that activate, rather than suppress, the immune system. Therefore, we introduce injectable conductive hydrogels engineered to match the softness of brain tissue while exhibiting electrical conductivities up to three orders of magnitude higher than any previously reported injectable hydrogels. They can be implanted through minimally invasive syringe capillaries as narrow as 30 µm-avoiding brain tissue damage-and via convection-enhanced delivery (CED) or endovascular catheters, the latter potentially eliminating the need for open brain surgery. Additionally, it can drape a resection cavity to eliminate residual tumor cells. In human glioblastoma tumors in the chicken chorioallantoic membrane model, implantation of the electrode using CED, followed by irreversible electroporation, obliterated tumors within three days. Other injection techniques impaired tumor growth, induced immunogenic cell death, and a robust infiltration of helper and cytotoxic T cells, alongside macrophages, highlighting the immune-activating and tumor-targeting capabilities.
Přístupová URL adresa: https://doi.org/10.1038/s41467-025-65785-x
Databáze: SwePub
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://doi.org/10.1038/s41467-025-65785-x#
    Name: EDS - SwePub (s4221598)
    Category: fullText
    Text: View record in SwePub
  – Url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pmc&term=2041-1723[TA]+AND+[PG]+AND+2025[PDAT]
    Name: FREE - PubMed Central (ISSN based link)
    Category: fullText
    Text: Full Text
    Icon: https://imageserver.ebscohost.com/NetImages/iconPdf.gif
    MouseOverText: Check this PubMed for the article full text.
  – Url: https://resolver.ebscohost.com/openurl?sid=EBSCO:edsswe&genre=article&issn=20411723&ISBN=&volume=16&issue=1&date=20251103&spage=&pages=&title=Nature Communications&atitle=Injectable%20bioresorbable%20conductive%20hydrogels%20for%20multimodal%20brain%20tumor%20electroimmunotherapy&aulast=Yadav%2C%20Amit%20Singh&id=DOI:10.1038/s41467-025-65785-x
    Name: Full Text Finder
    Category: fullText
    Text: Full Text Finder
    Icon: https://imageserver.ebscohost.com/branding/images/FTF.gif
    MouseOverText: Full Text Finder
  – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Yadav%20AS
    Name: ISI
    Category: fullText
    Text: Nájsť tento článok vo Web of Science
    Icon: https://imagesrvr.epnet.com/ls/20docs.gif
    MouseOverText: Nájsť tento článok vo Web of Science
Header DbId: edsswe
DbLabel: SwePub
An: edsswe.oai.portal.research.lu.se.publications.e5812ebc.0237.463e.9b40.4f36efdcec98
RelevancyScore: 1124
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1123.90246582031
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yadav%2C+Amit+Singh%22">Yadav, Amit Singh</searchLink><br /><searchLink fieldCode="AR" term="%22Aydemir%2C+Umut%22">Aydemir, Umut</searchLink><br /><searchLink fieldCode="AR" term="%22Hellman%2C+Karin%22">Hellman, Karin</searchLink><br /><searchLink fieldCode="AR" term="%22Ekström%2C+Peter%22">Ekström, Peter</searchLink><br /><searchLink fieldCode="AR" term="%22Mousa%2C+Abdelrazek+H%22">Mousa, Abdelrazek H</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+Jiaxin%22">Li, Jiaxin</searchLink><br /><searchLink fieldCode="AR" term="%22Shameem%2C+Muhammad+Anwar%22">Shameem, Muhammad Anwar</searchLink><br /><searchLink fieldCode="AR" term="%22Dicko%2C+Cedric%22">Dicko, Cedric</searchLink><br /><searchLink fieldCode="AR" term="%22Bengzon%2C+Johan%22">Bengzon, Johan</searchLink><br /><searchLink fieldCode="AR" term="%22Ek%2C+Fredrik%22">Ek, Fredrik</searchLink><br /><searchLink fieldCode="AR" term="%22Hjort%2C+Martin%22">Hjort, Martin</searchLink><br /><searchLink fieldCode="AR" term="%22Olsson%2C+Roger%22">Olsson, Roger</searchLink>
– Name: Author
  Label: Contributors
  Group: Au
  Data: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson's disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson's disease, Originator<br />Lund University, Faculty of Medicine, Department of Experimental Medical Science, Chemical Biology and Therapeutics, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Kemisk biologi med inriktning mot läkemedelsutveckling, Originator<br />Lund University, Faculty of Medicine, Department of Experimental Medical Science, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Originator<br />Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator<br />Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator<br />Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator<br />Lund University, Faculty of Science, Department of Physics, Particle and nuclear physics, Lunds universitet, Naturvetenskapliga fakulteten, Fysiska institutionen, Partikel- och kärnfysik, Originator<br />Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator<br />Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Neurosurgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Neurokirurgi, Originator<br />Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator<br />Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Originator<br />Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of stem cell research, Stem Cell Center, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för stamcellsforskning, Stamcellscentrum (SCC), Originator<br />Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Food and Bio, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Livsmedel och bioteknik, Originator<br />Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator<br />Lund University, Faculty of Science, Department of Chemistry, Center for Molecular Protein Science, Pure and Applied Biochemistry, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för Molekylär Proteinvetenskap, Tillämpad biokemi, Originator<br />Lund University, Faculty of Science, Department of Chemistry, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Originator<br />Lund University, Faculty of Engineering, LTH, Other operations, LTH, Lund Laser Centre, LLC, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Lunds lasercentrum, LLC, Originator<br />Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator<br />Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator<br />Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator<br />Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Epilepsy Center, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Epilepsicentrum, Originator<br />Lund University, Faculty of Science, Department of Chemistry, Centre for Analysis and Synthesis, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för analys och syntes, Originator
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <i>Nature Communications</i>. 16(1)
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Medical+and+Health+Sciences%22">Medical and Health Sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+Medicine%22">Clinical Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+and+Oncology%22">Cancer and Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22Medicin+och+hälsovetenskap%22">Medicin och hälsovetenskap</searchLink><br /><searchLink fieldCode="DE" term="%22Klinisk+medicin%22">Klinisk medicin</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+och+onkologi%22">Cancer och onkologi</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Current electrode technologies are too rigid for safe and effective delivery of electrotherapy in the brain, and patients with glioblastoma continue to face a devastating prognosis, with median survival stalled at 15 months despite intensive treatment with surgery, radiation, and chemotherapy. But these conventional approaches potentially compromise immune function, underscoring the urgent need for therapies that activate, rather than suppress, the immune system. Therefore, we introduce injectable conductive hydrogels engineered to match the softness of brain tissue while exhibiting electrical conductivities up to three orders of magnitude higher than any previously reported injectable hydrogels. They can be implanted through minimally invasive syringe capillaries as narrow as 30 µm-avoiding brain tissue damage-and via convection-enhanced delivery (CED) or endovascular catheters, the latter potentially eliminating the need for open brain surgery. Additionally, it can drape a resection cavity to eliminate residual tumor cells. In human glioblastoma tumors in the chicken chorioallantoic membrane model, implantation of the electrode using CED, followed by irreversible electroporation, obliterated tumors within three days. Other injection techniques impaired tumor growth, induced immunogenic cell death, and a robust infiltration of helper and cytotoxic T cells, alongside macrophages, highlighting the immune-activating and tumor-targeting capabilities.
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doi.org/10.1038/s41467-025-65785-x" linkWindow="_blank">https://doi.org/10.1038/s41467-025-65785-x</link>
PLink https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsswe&AN=edsswe.oai.portal.research.lu.se.publications.e5812ebc.0237.463e.9b40.4f36efdcec98
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-65785-x
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Medical and Health Sciences
        Type: general
      – SubjectFull: Clinical Medicine
        Type: general
      – SubjectFull: Cancer and Oncology
        Type: general
      – SubjectFull: Medicin och hälsovetenskap
        Type: general
      – SubjectFull: Klinisk medicin
        Type: general
      – SubjectFull: Cancer och onkologi
        Type: general
    Titles:
      – TitleFull: Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yadav, Amit Singh
      – PersonEntity:
          Name:
            NameFull: Aydemir, Umut
      – PersonEntity:
          Name:
            NameFull: Hellman, Karin
      – PersonEntity:
          Name:
            NameFull: Ekström, Peter
      – PersonEntity:
          Name:
            NameFull: Mousa, Abdelrazek H
      – PersonEntity:
          Name:
            NameFull: Li, Jiaxin
      – PersonEntity:
          Name:
            NameFull: Shameem, Muhammad Anwar
      – PersonEntity:
          Name:
            NameFull: Dicko, Cedric
      – PersonEntity:
          Name:
            NameFull: Bengzon, Johan
      – PersonEntity:
          Name:
            NameFull: Ek, Fredrik
      – PersonEntity:
          Name:
            NameFull: Hjort, Martin
      – PersonEntity:
          Name:
            NameFull: Olsson, Roger
      – PersonEntity:
          Name:
            NameFull: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson's disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson's disease, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Experimental Medical Science, Chemical Biology and Therapeutics, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Kemisk biologi med inriktning mot läkemedelsutveckling, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Experimental Medical Science, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Science, Department of Physics, Particle and nuclear physics, Lunds universitet, Naturvetenskapliga fakulteten, Fysiska institutionen, Partikel- och kärnfysik, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Neurosurgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Neurokirurgi, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of stem cell research, Stem Cell Center, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för stamcellsforskning, Stamcellscentrum (SCC), Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Food and Bio, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Livsmedel och bioteknik, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Science, Department of Chemistry, Center for Molecular Protein Science, Pure and Applied Biochemistry, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för Molekylär Proteinvetenskap, Tillämpad biokemi, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Science, Department of Chemistry, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Engineering, LTH, Other operations, LTH, Lund Laser Centre, LLC, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Lunds lasercentrum, LLC, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Epilepsy Center, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Epilepsicentrum, Originator
      – PersonEntity:
          Name:
            NameFull: Lund University, Faculty of Science, Department of Chemistry, Centre for Analysis and Synthesis, Lunds universitet, Naturvetenskapliga fakulteten, Kemiska institutionen, Centrum för analys och syntes, Originator
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 20411723
            – Type: issn-locals
              Value: SWEPUB_FREE
            – Type: issn-locals
              Value: LU_SWEPUB
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature Communications
              Type: main
ResultId 1